HealthDay on MSN2d
Glucagon-Like Peptide-1 Receptor Agonists May Reduce Alcohol ConsumptionGlucagon-like peptide-1 receptor agonist (GLP-1 RA) use may reduce alcohol consumption and improve outcomes in some ...
News Medical on MSN4d
Impact of glucagon-like peptide-1 receptor agonists on alcohol consumptionThe impact of GLP-1 RAs on alcohol use is explored, showing potential benefits in reducing intake and cravings, but with ...
Pharmaceutical company Novo Nordisk has launched its mega-popular weight-loss drug Wegovy in China — but for a tiny fraction ...
A recent study found that glucagon-like peptide-1 receptor (GLP-1) agonists like semaglutide and liraglutide are effective in ...
A collection of studies presented at a recent American Heart Association (AHA) conference has confirmed the heart health benefits provided by the new anti-obesity drugs, semaglutide and tirzepatide, ...
Unlike scores of people who scrambled for the blockbuster drugs Ozempic and Wegovy to lose weight in recent years, Danielle ...
Certain whole foods like oats, avocados, and lentils can mimic the effects of Ozempic, boosting the release of your GLP-1.
Popular weight loss drugs have been linked to gastrointestinal, mental health, and vision problems, but the benefits appear ...
Inno Supps’ Trim Biome™ GLP-1 is designed to support the body’s natural production of GLP-1 through a unique blend of ...
News Medical on MSN5d
Exenatide, a GLP-1 analog, by IV during cardiac surgery did not reduce organ injury or deathA large-scale clinical trial found that intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) analog ...
6don MSN
Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback